Skip to content

Variation of Progesterone in IVF Cycles

Variation of Progesterone in IVF Cycles

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03519776
Enrollment
30
Registered
2018-05-09
Start date
2018-05-10
Completion date
2019-03-31
Last updated
2020-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Progesterone Resistance

Brief summary

to examine if a natural daytime variation in progesterone levels may explain parts of the inconsistent findings from studies reporting divergent results concerning this matter and will be carried out by several blood samples from the same patient during the day of ovulation triggering.

Detailed description

The impact of the progesterone level at the end of the follicular phase in stimulated IVF/ICSI cycles and its effect on the pregnancy rate and oocyte quality is controversial, which arises from conflicting results in retrospective studies and meta-analyses. This study is assumed to examine if a natural daytime variation in progesterone levels may explain parts of the inconsistent findings from studies reporting divergent results concerning this matter and will be carried out by several blood samples from the same patient during the day of ovulation triggering. If variation is present, the impact of variation on the developing oocyte and embryo quality will be estimated by embryo quality indicators.

Interventions

DIAGNOSTIC_TESTProgesterone variation

The potential gain for medical caretakers and patients would be a certainty if the progesterone level is affected by variations during daytime

Sponsors

ART Fertility Clinics LLC
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* patients 18-45 years * BMI 18-35 kg/m2 * Menstrual cycle length 24-35 days * Stimulation with rFSH or hMG

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
The variation of serum progesterone around the ovulation triggering in IVF-cycles6-8 monthsthe circadian secretion-pattern of progesterone during early follicular phase of normal cycling females

Countries

United Arab Emirates

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026